Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nutriband Inc. - Warrant
(NQ:
NTRBW
)
4.000
UNCHANGED
Streaming Delayed Price
Updated: 3:27 PM EDT, Jul 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Nutriband Inc. - Warrant
< Previous
1
2
3
4
5
Next >
Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval
July 02, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index
July 01, 2025
From
Nutriband Inc.
Via
GlobeNewswire
NUTRIBAND AND KINDEVA COMPLETE COMMERCIAL MANUFACTURING PROCESS SCALE-UP FOR AVERSA™ FENTANYL ABUSE DETERRENT FENTANYL PATCH
June 18, 2025
Nutriband and Kindeva have completed commercial manufacturing process scale-up for its lead product Aversa™ Fentanyl, an abuse-deterrent fentanyl patch. Nutriband is partnering with Kindeva to develop...
Via
FinancialNewsMedia
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica
October 17, 2024
Via
ACCESSWIRE
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
June 18, 2025
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:PFE),(NASDAQ:COLL),(NYSE:TEVA),(NYSE:EBS) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
June 18, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
June 18, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology
June 09, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference
June 03, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
June 02, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband CEO Publishes Letter to Shareholders
April 30, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
April 11, 2025
Nutriband granted patent protecting its AVERSA abuse deterrent platform technology in Macao, a Special Administrative Region of the People’s Republic of China
From
Nutriband Inc.
Via
GlobeNewswire
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC
April 04, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Signs Partnership Agreement with Charlotte FC
April 04, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
February 21, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
February 13, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
February 11, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
February 07, 2025
The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe,...
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Issues Letter to Shareholders
December 31, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
December 27, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
December 04, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th
December 04, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
November 27, 2024
AVERSA Fentanyl has the potential to be the world's first and only abuse-deterrent opioid patch
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application
October 31, 2024
Via
ACCESSWIRE
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17
October 02, 2024
Via
ACCESSWIRE
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
September 24, 2024
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END
Via
FinancialNewsMedia
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
September 24, 2024
From
FN Media Group LLC
Via
GlobeNewswire
NUTRIBAND RECEIVES CHINA PATENT NOTICE OF ALLOWANCE FOR ITS AVERSA™ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY
September 24, 2024
Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for a patent application covering its Nutriband AVERSA™ abuse deterrent transdermal technology Nutriband...
Via
FinancialNewsMedia
Topics
Intellectual Property
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology
September 24, 2024
Via
ACCESSWIRE
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch
September 20, 2024
Via
ACCESSWIRE
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.